Minoryx Therapeutics’ Post

View organization page for Minoryx Therapeutics, graphic

6,739 followers

New data published in Brain showing that #leriglitazone halts disease progression in adult patients with progressive #cALD, a fatal neurodegenerative disorder characterized by growing, demyelinating brain lesions.

Leriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy in compassionate-use study published in Brain

Leriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy in compassionate-use study published in Brain

minoryx.com

To view or add a comment, sign in

Explore topics